Resitu is a developer of an innovative solution for breast cancer biopsies
Resitu has raised €737k across 1 funding round from 2 investors, most recently a round in Jul 2021. Based in Stockholm, Sweden; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-01 | Other | €737k |
| Almi Invest,STOAF III Scitech |
| View deal → |
